DK1507863T3 - Plasmidstabilisering in vivo - Google Patents

Plasmidstabilisering in vivo

Info

Publication number
DK1507863T3
DK1507863T3 DK03752862T DK03752862T DK1507863T3 DK 1507863 T3 DK1507863 T3 DK 1507863T3 DK 03752862 T DK03752862 T DK 03752862T DK 03752862 T DK03752862 T DK 03752862T DK 1507863 T3 DK1507863 T3 DK 1507863T3
Authority
DK
Denmark
Prior art keywords
plasmid
methods
vivo
host cells
maintaining
Prior art date
Application number
DK03752862T
Other languages
English (en)
Inventor
Julian Hanak
Rocky Cranenburgh
Scott Gorman
Original Assignee
Cobra Biolog Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cobra Biolog Ltd filed Critical Cobra Biolog Ltd
Application granted granted Critical
Publication of DK1507863T3 publication Critical patent/DK1507863T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK03752862T 2002-05-18 2003-05-19 Plasmidstabilisering in vivo DK1507863T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0211459.3A GB0211459D0 (en) 2002-05-18 2002-05-18 Plasmid stabilisation in vivo
PCT/GB2003/002166 WO2003097838A1 (en) 2002-05-18 2003-05-19 Plasmid stabilisation in vivo

Publications (1)

Publication Number Publication Date
DK1507863T3 true DK1507863T3 (da) 2007-05-07

Family

ID=9936960

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03752862T DK1507863T3 (da) 2002-05-18 2003-05-19 Plasmidstabilisering in vivo

Country Status (11)

Country Link
EP (1) EP1507863B1 (da)
AT (1) ATE349539T1 (da)
AU (1) AU2003232336A1 (da)
DE (1) DE60310708T2 (da)
DK (1) DK1507863T3 (da)
ES (1) ES2279963T3 (da)
GB (1) GB0211459D0 (da)
PT (1) PT1507863E (da)
SI (1) SI1507863T1 (da)
WO (1) WO2003097838A1 (da)
ZA (1) ZA200410202B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005271247A1 (en) * 2004-08-13 2006-02-16 The Trustees Of The University Of Pennsylvania Antibiotic resistance free DNA vaccines
EP2942391B1 (en) 2004-08-13 2018-05-23 The Trustees Of The University Of Pennsylvania Methods for constructing antibiotic resistance free vaccines
US9217153B2 (en) * 2009-05-22 2015-12-22 Merial, Inc. Antibiotic-free plasmids
CA2889069C (en) 2012-10-15 2021-01-26 University Of Maryland, Baltimore Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518395D0 (en) * 1995-09-08 1995-11-08 Therexsys Ltd Plasmid stabilization
US6780405B1 (en) * 2000-04-28 2004-08-24 Avant Immunotherapeutics, Inc. Regulated antigen delivery system (RADS)

Also Published As

Publication number Publication date
DE60310708T2 (de) 2007-10-31
EP1507863A1 (en) 2005-02-23
DE60310708D1 (de) 2007-02-08
ES2279963T3 (es) 2007-09-01
GB0211459D0 (en) 2002-06-26
AU2003232336A1 (en) 2003-12-02
WO2003097838A1 (en) 2003-11-27
SI1507863T1 (sl) 2007-06-30
PT1507863E (pt) 2007-03-30
ZA200410202B (en) 2006-08-30
EP1507863B1 (en) 2006-12-27
ATE349539T1 (de) 2007-01-15

Similar Documents

Publication Publication Date Title
ES2768976T3 (es) Edición de genoma mediada por nucleasa
TR201909609T4 (tr) Modifiye edilmiş nükleosidleri içeren rna ve kullanım yöntemleri.
EP1476562A4 (en) OVEREXPRESSION OF EXTREMOZYME GENES IN PSEUDOMONAL BACTERIA AND CLOSELY BOUNDED BACTERIA
ATE323169T1 (de) Plasmid zur verabreichung von nukleine säuren und verwendungsverfahren
CY1111060T1 (el) Νουκλεϊκα οξεα χρησιμα για την πυροδοτηση της θνησιμοτητας κυτταρων ογκου
WO2005062881A3 (en) Gene therapy using transposon-based vectors
BR9814546A (pt) "liberação de dna de plasmìdeo codificando polipeptìdeos no citossol de macrófagos por bactérias suicidas atenuadas"
WO2004067753A3 (en) Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
ATE284898T1 (de) Synthetische papillomavirus gene, welche für expression in menschlichen zellen optimiert sind
Razin et al. Nuclear matrix attachment regions and topoisomerase II binding and reaction sites in the vicinity of a chicken DNA replication origin
DK1526840T3 (da) Nanopartikler til DNA administration til et målorgan
MXPA05003818A (es) Perfilamiento de la expresion genica de muestras ffpe.
DK1507863T3 (da) Plasmidstabilisering in vivo
GB0418388D0 (en) Cell therapy
MXPA05008817A (es) Derivados de esteres lipidos de nucleotidos.
ATE338826T1 (de) Rekombinante virale vektoren zur tetracyclinregulierbaren genexpression
EP2272527A3 (en) Combined DNA vaccine and biological modifiers for cancer therapy
DE60002603D1 (de) Phosphor-enthaltende dendrimere als transfektionsagente
WO2004001027A8 (en) Oligonucleotide inhibitors of mbd2/dna demethylase and uses thereof
RS104404A (en) Control sequences of the human corin gene
BRPI0415296A (pt) cdna modificado para os nìveis de expressão elevados do fator viii e seus derivados
ATE315406T1 (de) Semi-allogene antitumor-vakzine mit hla-haplo- identischen antigen-präsentierenden zellen
CU23400A1 (es) Método para la obtención de minicírculos replicativos de adn para transferencia génica o como inmunomoduladores
WO2004032973A3 (en) Use of sns insulator of sea urchin for the gene therapy of erythroid cell diseases
WO2024079530A3 (en) Nucleic acid regulatory elements for gene expression in the muscle and methods of use